StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences long-term debt, noncurrent ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, FY2025
22,129
Period ended Dec 31, 2025
Change on a year earlier
-11.1%
24,896 in FY2024
History
15 years
Since FY2011
Sources
14
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLong-term debt, noncurrent ($M) ($M)Year on yearSource
FY2025Dec 31, 202522,129-11.1%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202424,896+7.4%Form 10-K (filed 2025-02-28) ↗
FY2023Dec 31, 202323,189+1.0%Form 10-K (filed 2024-02-23) ↗
FY2022Dec 31, 202222,957-8.8%Form 10-K (filed 2023-02-22) ↗
FY2021Dec 31, 202125,179-12.1%Form 10-K (filed 2022-02-23) ↗
FY2020Dec 31, 202028,645+29.7%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 201922,094-10.1%Form 10-K (filed 2020-02-25) ↗
FY2018Dec 31, 201824,574-20.2%Form 10-K (filed 2019-02-26) ↗
FY2017Dec 31, 201730,795+16.9%Form 10-K (filed 2018-02-27) ↗
FY2016Dec 31, 201626,346+25.0%Form 10-K (filed 2017-02-27) ↗
FY2015Dec 31, 201521,073+76.8%Form 10-Q (filed 2016-05-06) ↗
FY2014Dec 31, 201411,921+202.6%Form 10-K (filed 2015-02-25) ↗
FY2013Dec 31, 20133,939-44.2%Form 10-K (filed 2015-02-25) ↗
FY2012Dec 31, 20127,055-7.2%Form 10-K (filed 2013-02-27) ↗
FY2011Dec 31, 20117,606–Form 10-Q (filed 2012-05-04) ↗

Cite this data

StockData. (2026). Gilead Sciences Long-term debt, noncurrent ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/fs_ltdebt

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.